Risk of Hospitalized Infection With DMARD or TNF-I Therapy for Ankylosing Spondylitis

October 17, 2018
Gregory M. Weiss, MD

Concerns have been raised in the past about the possibility of infection caused by immune suppression.

Related Content:

Ankylosing Spondylitis